← Open Payments lookup

JOHN GUINN: Open Payments

NPI 1386060010 · EL DORADO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$710 in 32 payments from 7 companies in 2025. Trend: 2023 $294 · 2024 $437 · 2025 $710

Food & beverage: $710
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$278
ABBVIE INC.12$244
Novo Nordisk Inc1$61
Otsuka America Pharmaceutical, Inc.2$55
Axsome Therapeutics, Inc.2$34
Neurocrine BioSciences, Inc.1$19
Supernus Pharmaceuticals, Inc.1$18

Products named: CAPLYTA, VRAYLAR, Wegovy, REXULTI, Auvelity, INGREZZA, Qelbree.

Industry payments across AR — which companies pay providers there.